Vanda Pharmaceuticals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Mihael Polymeropoulos
Chief executive officer
US$3.7m
Total compensation
| CEO salary percentage | 24.1% |
| CEO tenure | 21yrs |
| CEO ownership | 2.1% |
| Management average tenure | 5.3yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$4m | US$897k | US$3m |
| Sep 30 2023 | n/a | n/a | US$12m |
| Jun 30 2023 | n/a | n/a | US$15m |
| Mar 31 2023 | n/a | n/a | US$16m |
| Dec 31 2022 | US$4m | US$815k | US$6m |
| Sep 30 2022 | n/a | n/a | US$6m |
| Jun 30 2022 | n/a | n/a | US$11m |
| Mar 31 2022 | n/a | n/a | US$18m |
| Dec 31 2021 | US$6m | US$769k | US$33m |
| Sep 30 2021 | n/a | n/a | US$34m |
| Jun 30 2021 | n/a | n/a | US$32m |
| Mar 31 2021 | n/a | n/a | US$32m |
| Dec 31 2020 | US$3m | US$746k | US$23m |
| Sep 30 2020 | n/a | n/a | US$19m |
| Jun 30 2020 | n/a | n/a | US$114m |
| Mar 31 2020 | n/a | n/a | US$117m |
| Dec 31 2019 | US$4m | US$721k | US$116m |
| Sep 30 2019 | n/a | n/a | US$122m |
| Jun 30 2019 | n/a | n/a | US$28m |
| Mar 31 2019 | n/a | n/a | US$22m |
| Dec 31 2018 | US$4m | US$700k | US$25m |
| Sep 30 2018 | n/a | n/a | US$13m |
| Jun 30 2018 | n/a | n/a | US$1m |
| Mar 31 2018 | n/a | n/a | -US$5m |
| Dec 31 2017 | US$6m | US$675k | -US$16m |
Compensation vs Market: Mihael's total compensation ($USD3.72M) is above average for companies of similar size in the German market ($USD695.40K).
Compensation vs Earnings: Mihael's compensation has been consistent with company performance over the past year.
CEO
Mihael Polymeropoulos (63 yo)
21yrs
Tenure
US$3,720,215
Compensation
Dr. Mihael H. Polymeropoulos, M.D., founded Vanda Pharmaceuticals, Inc. in 2003. He serves as Chairman of The Board at Vanda Pharmaceuticals Inc since June 2021 and has been its Chief Executive Officer, Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 21yrs | US$3.72m | 2.15% $ 5.7m | |
| Senior VP | 4.2yrs | US$1.32m | 0.092% $ 241.4k | |
| Senior VP | 5.8yrs | US$1.40m | 0.039% $ 103.2k | |
| Senior VP & Chief Marketing Officer | 4.8yrs | US$1.36m | 0.086% $ 225.6k | |
| Senior Vice President of Business Development | 7.2yrs | US$1.37m | 0.54% $ 1.4m | |
| Chief People Officer | 4.8yrs | no data | no data |
5.3yrs
Average Tenure
54yo
Average Age
Experienced Management: VM4's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 21yrs | US$3.72m | 2.15% $ 5.7m | |
| Lead Independent Director | 18.4yrs | US$332.50k | 0.12% $ 310.0k | |
| Independent Director | 1.2yrs | US$602.43k | no data | |
| Independent Director | 4.6yrs | US$302.50k | 0.017% $ 45.3k | |
| Independent Director | 4.3yrs | US$282.50k | 0.021% $ 54.5k | |
| Independent Director | 4.6yrs | US$300.00k | 0.022% $ 58.6k |
4.6yrs
Average Tenure
67yo
Average Age
Experienced Board: VM4's board of directors are considered experienced (4.6 years average tenure).